Merck pulls the trigger on a new West Coast R&D campus in the heart of a mega-hub
Merck has staked out a new R&D campus for itself in the heart of South San Francisco, the epicenter of the Bay Area’s biotech mega-hub.
Alexandria Real Estate Equities, the builder of many biotech facilities around the country, will be breaking ground on the site soon after Merck bought into a new, 294,000-square-foot West Coast research complex at 213 East Grand Avenue. The move-in date is being set for 2019.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.